Twist Bioscience
TWST
P/S ratio for Twist Bioscience (TWST)
P/S ratio as of May 2024 (TTM): 9.76
According to Twist Bioscience 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.75728. At the end of 2023 the company had a P/S ratio of 8.10.
P/S ratio history for Twist Bioscience from 2018 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 8.10 | 29.82% |
| 2022 | 6.24 | -76.76% |
| 2021 | 26.9 | -60.16% |
| 2020 | 67.4 | 479.71% |
| 2019 | 11.6 | -41.37% |
| 2018 | 19.8 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 49.1 | 403.44% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 17.4 | 78.38% | 🇬🇧 UK |
 Novavax NVAX | 3.06 | -68.65% | 🇺🇸 USA |
 Novocure
NVCR | 4.54 | -53.49% | Jersey |